1. Clinical Research
Advanced radiotherapy techniques intensity modulated radiotherapy; stereotactic radiotherapy using tomotherapy, cyberknife and autosegmentation; nasopharyngeal carcinoma, especially its relationship with the Epstein Barr virus and immunotherapy including T cell treatment; multimodality treatment that aims at improving control and minimising side effects; multimodality treatment of brain tumours, colorectal, oesophageal cancer, breast cancer, and thyroid cancer, and elucidation of related prognostic factors.
2. Identification and Characterisation of Cancer-Related Genes
Elucidation of the tumour pathogenesis and progression in hepatocellular carcinoma (HCC), nasopharyngeal carcinoma (NPC), colorectal cancer, oesophageal cancer, ovarian cancer, and lung cancer, through the characterization of isolated oncogenes or tumour suppressor genes with recently-developed techniques, such as next-generation sequencing analysis. Functional assays are used to study the roles of candidate genes in cancer development and progression.
3. Discovery and Validation of Candidate Genes in Nasopharyngeal and Oesophageal Cancers
For more information or to express interest to join the research areas, please email the supervisor or the specified contact point in the description. Interested candidates are advised to enclose with your email:
Research postgraduate studies enquiries specific to the department/school’s research should be directed to the Chairman of the Departmental Research Postgraduate Committee:
Professor XY Guan
Information on the research programme, funding support and admission documentations could be referenced online at the Research Postgraduate Admissions website.
General admission enquiries should be directed to firstname.lastname@example.org.